WHO ARE WE - OUR KEY DIFFERENTIATORS

STATE OF THE ART cGMP FACILITY

solution provider

SKYEPHARMA ACQUIRES A NEW MARCHESINI BOTTLING LINE

7 février 2018 –   4.1 million Investment results in upgrade to SKYEPHARMA Development & Manufacturing site...
Read More

Skyepharma Company Insight

24 janvier 2018 –   The ultimate solid dosage tool to accelerate time to market, Skyepharma,...
Read More
LOOKING FOR A CDMO PARTNER ?
Our unique selling point is to be a solution provider ensuring customer satisfaction.